Nialipin
60/100
Review before taking
- Niacin: 400mg is 11.4× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 400mg is 11.4× the Tolerable Upper Intake Level (35mg)
The safety score is low because the amount of niacin in this product is more than 11 times higher than the recommended maximum daily limit.
Label Data
1 Capsule(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
400 mg
(2000% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 11.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Gelatin
Sucrose
Food Glaze
Magnesium Silicate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Hypersensitive individuals are advised to start with one-half of a capsule before titrating up to a higher level. The hard gelatin capsules may be pulled apart and the beadlets removed.
DIRECTIONS As a dietary supplement: Take one or two capsules daily.
🧪 Formulation Notes
NIALIPIN is well-tolerated by sensitive individuals.
400 mg Timed-Release Niacin
Additional Information
ECOLOGICAL FORMULAS
10120537 EXP1013
Product Details
DSLD Entry Date
2013-06-25
Product Type
Vitamin
Form
Capsule
Brand
Cardiovascular Research
DSLD ID
22959
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100